Noble Wealth Management PBC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6K Buy
48
+2
+4% +$742 0.01% 410
2026
Q1
$13.5K Sell
46
-3
-6% -$986 0.01% 420
2025
Q4
$17.2K Hold
49
0.01% 397
2025
Q3
$15.8K Buy
+49
New +$15.2K 0.01% 393
2025
Q1
$21.3K Hold
49
0.01% 294
2024
Q4
$18.1K Buy
+49
New +$20.5K 0.01% 294

Other funds holding ELV

Noble Wealth Management PBC's ELV Position: Q2 2026 in Review

Noble Wealth Management PBC increased its Elevance Health (ELV) stake by 4.3% in Q2 2026, buying an estimated $742 and bringing the position to 48 shares worth $18.6K. The position accounts for 0.01% of the portfolio, ranked #410.

Noble Wealth Management PBC first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $21.3K in Q1 2025. 388 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Noble Wealth Management PBC held 48 shares of Elevance Health worth $18.6K as of Q2 2026.
  • Noble Wealth Management PBC bought 2 Elevance Health shares in Q2 2026, an estimated $742.
  • Elevance Health made up 0.01% of Noble Wealth Management PBC's portfolio in Q2 2026, its #410 holding.
  • Noble Wealth Management PBC first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • Noble Wealth Management PBC's Elevance Health position peaked at $21.3K in Q1 2025.
  • 388 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.